KMDA FY 2024 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$161M+12.9% YoY

Gross Profit

$70M43.5% margin

Operating Income

$20M12.5% margin

Net Income

$14M9.0% margin

EPS (Diluted)

$0.25

Cash Flow

Operating Cash Flow

$48M

Free Cash Flow

$37M

Stock-Based Comp.

$874,000

Balance Sheet

Total Assets

$372M

Total Liabilities

$113M

Stockholders' Equity

$259M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$161M	$143M	+12.9%
Gross Profit	$70M	$55M	+26.1%
Operating Income	$20M	$10M	+99.2%
Net Income	$14M	$8M	+74.6%